Session

Biomarkers in liver diseases

ELASTOGRAPHIC PARAMETER OF LIVER STEATOSIS AND FIBROSIS INDEPENDENTLY PREDICT THE DEVELOPMENT OF CHRONIC VASCULAR C COMPLICATIONS OF TYPE 2 DIABETES - A PROSPECTIVE OBSERVATIONAL STUDY
ELASTOGRAPHIC PARAMETER OF LIVER STEATOSIS AND FIBROSIS INDEPENDENTLY PREDICT THE DEVELOPMENT OF CHRONIC VASCULAR C COMPLICATIONS OF TYPE 2 DIABETES - A PROSPECTIVE OBSERVATIONAL STUDY

A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS
A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS

MACHINE LEARNING IN PRIMARY BILIARY CHOLANGITIS: A NOVEL APPROACH FOR RISK STRATIFICATION
MACHINE LEARNING IN PRIMARY BILIARY CHOLANGITIS: A NOVEL APPROACH FOR RISK STRATIFICATION

THE INFLUENCE OF GENETIC VARIANTS PNPLA3, TM6SF2, AND MBOAT7 ON THE RESPONSE TO A SILYBIN/VITAMIN D-BASED TREATMENT FOR METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE PATIENTS
THE INFLUENCE OF GENETIC VARIANTS PNPLA3, TM6SF2, AND MBOAT7 ON THE RESPONSE TO A SILYBIN/VITAMIN D-BASED TREATMENT FOR METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE PATIENTS

FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Biomarkers in liver diseases  et al.

THE INFLUENCE OF GENETIC VARIANTS PNPLA3, TM6SF2, AND MBOAT7 ON THE RESPONSE TO A SILYBIN/VITAMIN D-BASED TREATMENT FOR METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE PATIENTS
THE INFLUENCE OF GENETIC VARIANTS PNPLA3, TM6SF2, AND MBOAT7 ON THE RESPONSE TO A SILYBIN/VITAMIN D-BASED TREATMENT FOR METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE PATIENTS

Biomarkers in liver diseases  et al.

MACHINE LEARNING IN PRIMARY BILIARY CHOLANGITIS: A NOVEL APPROACH FOR RISK STRATIFICATION
MACHINE LEARNING IN PRIMARY BILIARY CHOLANGITIS: A NOVEL APPROACH FOR RISK STRATIFICATION

Biomarkers in liver diseases  et al.

A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS
A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS

Biomarkers in liver diseases  et al.

ELASTOGRAPHIC PARAMETER OF LIVER STEATOSIS AND FIBROSIS INDEPENDENTLY PREDICT THE DEVELOPMENT OF CHRONIC VASCULAR C COMPLICATIONS OF TYPE 2 DIABETES - A PROSPECTIVE OBSERVATIONAL STUDY
ELASTOGRAPHIC PARAMETER OF LIVER STEATOSIS AND FIBROSIS INDEPENDENTLY PREDICT THE DEVELOPMENT OF CHRONIC VASCULAR C COMPLICATIONS OF TYPE 2 DIABETES - A PROSPECTIVE OBSERVATIONAL STUDY

Biomarkers in liver diseases  et al.

Item 1 - 10 / 10
1